In the past week, LIPO stock has gone down by -22.45%, with a monthly gain of 17.54% and a quarterly surge of 32.94%. The volatility ratio for the week is 12.26%, and the volatility levels for the last 30 days are 13.27% for Lipella Pharmaceuticals Inc The simple moving average for the past 20 days is 3.99% for LIPO’s stock, with a -11.07% simple moving average for the past 200 days.
Is It Worth Investing in Lipella Pharmaceuticals Inc (NASDAQ: LIPO) Right Now?
Additionally, the 36-month beta value for LIPO is 0.25. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for LIPO is 0.90M and currently, short sellers hold a 3.42% ratio of that float. The average trading volume of LIPO on February 20, 2025 was 2.29M shares.
LIPO) stock’s latest price update
The stock price of Lipella Pharmaceuticals Inc (NASDAQ: LIPO) has dropped by -6.94 compared to previous close of 3.60. Despite this, the company has seen a fall of -22.45% in its stock price over the last five trading days. prismmediawire.com reported 2025-02-11 that PITTSBURGH, Feb. 11, 2025 – PRISM MediaWire – Lipella Pharmaceuticals Inc.
LIPO Trading at 9.07% from the 50-Day Moving Average
After a stumble in the market that brought LIPO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -72.08% of loss for the given period.
Volatility was left at 13.27%, however, over the last 30 days, the volatility rate increased by 12.26%, as shares surge +17.13% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +20.94% upper at present.
During the last 5 trading sessions, LIPO fell by -22.45%, which changed the moving average for the period of 200-days by -42.41% in comparison to the 20-day moving average, which settled at $3.22. In addition, Lipella Pharmaceuticals Inc saw 9.84% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at LIPO starting from Kaufman Jonathan H, who purchase 10,000 shares at the price of $0.76 back on May 14 ’24. After this action, Kaufman Jonathan H now owns 898,849 shares of Lipella Pharmaceuticals Inc, valued at $7,590 using the latest closing price.
Kaufman Jonathan H, the below. of Lipella Pharmaceuticals Inc, purchase 30,000 shares at $0.79 during a trade that took place back on Mar 18 ’24, which means that Kaufman Jonathan H is holding 863,849 shares at $23,649 based on the most recent closing price.
Stock Fundamentals for LIPO
Current profitability levels for the company are sitting at:
- -0.03 for the present operating margin
- 0.99 for the gross margin
The net margin for Lipella Pharmaceuticals Inc stands at -17.43. The total capital return value is set at -0.0. Equity return is now at value -231.67, with -170.50 for asset returns.
Based on Lipella Pharmaceuticals Inc (LIPO), the company’s capital structure generated 0.05 points at debt to capital in total, while cash flow to debt ratio is standing at -41805.22.
Currently, EBITDA for the company is -4.61 million with net debt to EBITDA at 0.3. When we switch over and look at the enterprise to sales, we see a ratio of 0.02. The receivables turnover for the company is 4400.98for trailing twelve months and the total asset turnover is 0.06. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.97.
Conclusion
In conclusion, Lipella Pharmaceuticals Inc (LIPO) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
